% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

  • smallcaproi smallcaproi Apr 18, 2013 9:02 AM Flag

    Another Napodano pick: DARA: $2 DCF, well-financed, 2 drugs revenues by end of year

    Another Napodano biotech pick - DARA Biosciences. DCF analysis yields a fair value of $2/sh, based on a 4-drug pipeline, two of which are expected to be earning revenues by the end of this year. See the author PropThink on SeekingAlpha.

    Sentiment: Strong Buy

8.23+0.88(+11.97%)Nov 25 4:00 PMEST